Faculty Collaboration Database

Nonpharmacologic and pharmacologic management of CPP crystal arthritis and BCP arthropathy and periarticular syndromes. Rheum Dis Clin North Am 2014 May;40(2):343-56

Date

04/08/2014

Pubmed ID

24703351

Pubmed Central ID

PMC6240445

DOI

10.1016/j.rdc.2014.01.010

Scopus ID

2-s2.0-84898599073 (requires institutional sign-in at Scopus site)   15 Citations

Abstract

Calcium crystal arthritis is often unrecognized, poorly managed, and few effective therapies are available. The most common types of calcium crystals causing musculoskeletal syndromes are calcium pyrophosphate (CPP) and basic calcium phosphate (BCP). Associated syndromes have different clinical presentations and divergent management strategies. Acute CPP arthritis is treated similarly to acute gouty arthritis, whereas chronic CPP and BCP arthropathy may respond to strategies used for osteoarthritis. Calcific tendonitis is treated with a variety of interventions designed to dissolve BCP crystals. A better understanding of the causes and larger well-planned trials of current therapies will lead to improved care.

Author List

Rosenthal AK, Ryan LM

Author

Ann K. Rosenthal MD Associate Dean, Chief, Professor in the Medicine department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Adrenal Cortex Hormones
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Calcinosis
Calcium Phosphates
Chondrocalcinosis
Colchicine
Durapatite
Gout Suppressants
High-Energy Shock Waves
Humans
Interleukin 1 Receptor Antagonist Protein
Periarthritis
Tendinopathy